403 results on '"Elinder, Carl-Gustaf"'
Search Results
52. Mortality in a Region Surrounding an Arsenic Emitting Plant
- Author
-
Pershagen, Göran, Elinder, Carl-Gustaf, and Bolander, Anne-Marie
- Published
- 1977
- Full Text
- View/download PDF
53. Biliary Excretion of Cadmium
- Author
-
Elinder, Carl-Gustaf and Pannone, Maud
- Published
- 1979
- Full Text
- View/download PDF
54. Cadmium May Be a Risk Factor for Osteoporosis
- Author
-
Järup, Lars, Alfvén, Tobias, Persson, Bodil, Toss, Göran, and Elinder, Carl Gustaf
- Published
- 1998
55. Health effects of cadmium exposure – a review of the literature and a risk estimate
- Author
-
Järup, Lars, Berglund, Marika, Elinder, Carl Gustaf, Nordberg, Gunnar, and Vanter, Marie
- Published
- 1998
56. Blood cadmium as an indicator of dose in a long-term follow-up of workers previously exposed to cadmium
- Author
-
Järup, Lars, Persson, Bodil, and Elinder, Carl-Gustaf
- Published
- 1997
57. Estimation of Benchmark Dose of Cumulative Cadmium Exposure for Renal Tubular Effect
- Author
-
Nogawa, Kazuhiro, primary, Suwazono, Yasushi, additional, Watanabe, Yuuka, additional, and Elinder, Carl-Gustaf, additional
- Published
- 2021
- Full Text
- View/download PDF
58. Ascorbic Acid Supplements and Kidney Stone Incidence Among Men: A Prospective Study
- Author
-
Thomas, Laura D., Elinder, Carl-Gustaf, Tiselius, Hans-Göran, Wolk, Alicja, and Åkesson, Agneta
- Published
- 2013
- Full Text
- View/download PDF
59. Acetaminophen, aspirin, and chronic renal failure
- Author
-
Fored, C. Michael, Ejerblad, Elisabeth, Lindblad, Per, Fryzek, Jon P., Dickman, Paul W., Signorello, Lisa B., Lipworth, Loren, Elinder, Carl-Gustaf, Blot, William J., McLaughlin, Joseph K., Zack, Matthew M., and Nyren, Olof
- Subjects
Chronic kidney failure -- Causes of ,Aspirin -- Adverse and side effects ,Acetaminophen -- Adverse and side effects - Abstract
The chronic use of acetaminophen or aspirin can damage the kidneys, according to a study of 1,898 people. Those who used acetaminophen or aspirin were more likely to develop chronic kidney failure than those who did not.
- Published
- 2001
60. “Dysmorphic” lysosomes in proximal tubular cells are not specific for CINAC/CKDu and do not provide evidence that CINAC/CKDu is a toxin-induced disease
- Author
-
Wijkström, Julia, primary, Elinder, Carl-Gustaf, additional, Hultenby, Kjell, additional, Söderberg, Magnus, additional, and Wernerson, Annika, additional
- Published
- 2020
- Full Text
- View/download PDF
61. Aluminum
- Author
-
SJÖGREN, BENGT, primary, IREGREN, ANDERS, additional, ELINDER, CARL-GUSTAF, additional, and YOKEL, ROBERT A., additional
- Published
- 2007
- Full Text
- View/download PDF
62. Variations in graft and patient survival after kidney transplantation in Sweden: caveats in interpretation of center effects when benchmarking
- Author
-
Elinder, Carl-Gustaf, Ekberg, Henrik, Bárány, Peter, Fehrman-Ekholm, Ingela, Jensen, Gert, Nordén, Gunnela, Schön, Staffan, Wennberg, Lars, and Qureshi, Abdul Rashid
- Published
- 2009
- Full Text
- View/download PDF
63. Acetaminophen, aspirin and progression of advanced chronic kidney disease
- Author
-
Evans, Marie, Fored, Carl Michael, Bellocco, Rino, Fitzmaurice, Garrett, Fryzek, Jon P., Mclaughlin, Joseph K., Nyrén, Olof, and Elinder, Carl-Gustaf
- Published
- 2009
64. No evidence of renal toxicity from amalgam fillings
- Author
-
Sandborgh-Englund, Gunilla, Nygren, Anders T., Ekstrand, Jan, and Elinder, Carl-Gustaf
- Subjects
Mercury -- Physiological aspects ,Dental amalgams -- Physiological aspects ,Toxicity testing -- In vivo ,Biological sciences - Abstract
The renal activities of 10 healthy human volunteers were analyzed after exposure to inorganic mercury from amalgam fillings during dental treatment. Exposure of human subjects to inorganic mercury during amalgam removal did not produce any renal toxic effects. However, the concentrations of inorganic mercury increased in the plasma after amalgam removal but blood mercury levels and urinary excretion rate decreased two months after the treatment.
- Published
- 1996
65. Development of Risk Prediction Equations for Incident Chronic Kidney Disease
- Author
-
Nelson, Robert G., Grams, Morgan E., Ballew, Shoshana H., Sang, Yingying, Azizi, Fereidoun, Chadban, Steven J., Chaker, Layal, Dunning, Stephan C., Fox, Caroline, Hirakawa, Yoshihisa, Iseki, Kunitoshi, Ix, Joachim, Jafar, Tazeen H., Koettgen, Anna, Naimark, David M. J., Ohkubo, Takayoshi, Prescott, Gordon J., Rebholz, Casey M., Sabanayagam, Charumathi, Sairenchi, Toshimi, Schoettker, Ben, Shibagaki, Yugo, Tonelli, Marcello, Zhang, Luxia, Gansevoort, Ron T., Matsushita, Kunihiro, Woodward, Mark, Coresh, Josef, Shalev, Varda, Chalmers, John, Arima, Hisatomi, Perkovic, Vlado, Grams, Morgan, Polkinghorne, Kevan, Atkins, Robert, Chadban, Steven, Liu, Lisheng, Zhao, Ming-Hui, Wang, Fang, Wang, Jinwei, Sacks, Frank M., Curhan, Gary C., Shlipak, Michael, Sarnak, Mark J., Katz, Ronit, Hiramoto, Jade, Iso, Hiroyasu, Muraki, Isao, Yamagishi, Kazumasa, Umesawa, Mitsumasa, Brenner, Hermann, Saum, Kai-Uwe, Rothenbacher, Dietrich, Fox, Caroline S., Hwang, Shih-Jen, Chang, Alex R., Green, Jamie, Singh, Gurmukteshwar, Kirchner, H. Lester, Black, Corri, Marks, Angharad, Clark, Laura, Fluck, Nick, Cirillo, Massimo, Hallan, Stein, Ovrehus, Marius, Langlo, Knut Asbjorn, Romundstad, Solfrid, Irie, Fujiko, Correa, Adolfo, Young, Bessie A., Boulware, L. Ebony, Mwasongwe, Stanford, Watanabe, Tsuyoshi, Yamagata, Kunihiro, Asahi, Koichi, Chodick, Gabriel, Sarnak, Mark, Peralta, Carmen, Bottinger, Erwin, Nadkarni, Girish N., Ellis, Stephen B., Nadukuru, Rajiv, Kenealy, Timothy, Elley, C. Raina, Collins, John F., Drury, Paul L., Asayama, Kei, Kikuya, Masahiro, Metoki, Hirohito, Nakayama, Masaaki, Iseki, Chiho, Looker, Helen C., Knowler, William C., Bakker, Stephan J. L., Heerspink, Hiddo J. L., Bernardo, Rancho, Jassal, Simerjot K., Bergstrom, Jaclyn, Ix, Joachim H., Barrett-Connor, Elizabeth, Kovesdy, Csaba P., Sumida, Keiichi, Kalantar-Zadeh, Kamyar, Sedaghat, Sanaz, Ikram, M. Arfan, Hoorn, Ewout J., Dehghan, Abbas, Carrero, Juan J., Evans, Marie, Elinder, Carl-Gustaf, Wettermark, Bjorn, Wong, Tien Y., Cheng, Ching-Yu, Sokor, Riswana Banu Binte Mohamed Abdul, Wen, Chi-Pang, Tsao, Chwen-Keng, Tsai, Min-Kuang, Chen, Chien-Hua, Hosseinpanah, Farhad, Hadaegh, Farzad, Mirbolouk, Mohammadhassan, Solbu, Marit Dahl, Eriksen, Bjorn Odvar, Jenssen, Trond Geir, Eggen, Anne Elise, Lannfelt, Lars, Larsson, Anders, Ärnlöv, Johan, Bilo, Henk J. G., Landman, Gijs W. D., van Hateren, Kornelis J. J., Kleefstra, Nanne, Stempniewicz, Nikita, Cuddeback, John, Ciemins, Elizabeth, Levey, Andrew S., Chen, Jingsha, Kwak, Lucia, Surapeneni, Aditya, Nelson, Robert G., Grams, Morgan E., Ballew, Shoshana H., Sang, Yingying, Azizi, Fereidoun, Chadban, Steven J., Chaker, Layal, Dunning, Stephan C., Fox, Caroline, Hirakawa, Yoshihisa, Iseki, Kunitoshi, Ix, Joachim, Jafar, Tazeen H., Koettgen, Anna, Naimark, David M. J., Ohkubo, Takayoshi, Prescott, Gordon J., Rebholz, Casey M., Sabanayagam, Charumathi, Sairenchi, Toshimi, Schoettker, Ben, Shibagaki, Yugo, Tonelli, Marcello, Zhang, Luxia, Gansevoort, Ron T., Matsushita, Kunihiro, Woodward, Mark, Coresh, Josef, Shalev, Varda, Chalmers, John, Arima, Hisatomi, Perkovic, Vlado, Grams, Morgan, Polkinghorne, Kevan, Atkins, Robert, Chadban, Steven, Liu, Lisheng, Zhao, Ming-Hui, Wang, Fang, Wang, Jinwei, Sacks, Frank M., Curhan, Gary C., Shlipak, Michael, Sarnak, Mark J., Katz, Ronit, Hiramoto, Jade, Iso, Hiroyasu, Muraki, Isao, Yamagishi, Kazumasa, Umesawa, Mitsumasa, Brenner, Hermann, Saum, Kai-Uwe, Rothenbacher, Dietrich, Fox, Caroline S., Hwang, Shih-Jen, Chang, Alex R., Green, Jamie, Singh, Gurmukteshwar, Kirchner, H. Lester, Black, Corri, Marks, Angharad, Clark, Laura, Fluck, Nick, Cirillo, Massimo, Hallan, Stein, Ovrehus, Marius, Langlo, Knut Asbjorn, Romundstad, Solfrid, Irie, Fujiko, Correa, Adolfo, Young, Bessie A., Boulware, L. Ebony, Mwasongwe, Stanford, Watanabe, Tsuyoshi, Yamagata, Kunihiro, Asahi, Koichi, Chodick, Gabriel, Sarnak, Mark, Peralta, Carmen, Bottinger, Erwin, Nadkarni, Girish N., Ellis, Stephen B., Nadukuru, Rajiv, Kenealy, Timothy, Elley, C. Raina, Collins, John F., Drury, Paul L., Asayama, Kei, Kikuya, Masahiro, Metoki, Hirohito, Nakayama, Masaaki, Iseki, Chiho, Looker, Helen C., Knowler, William C., Bakker, Stephan J. L., Heerspink, Hiddo J. L., Bernardo, Rancho, Jassal, Simerjot K., Bergstrom, Jaclyn, Ix, Joachim H., Barrett-Connor, Elizabeth, Kovesdy, Csaba P., Sumida, Keiichi, Kalantar-Zadeh, Kamyar, Sedaghat, Sanaz, Ikram, M. Arfan, Hoorn, Ewout J., Dehghan, Abbas, Carrero, Juan J., Evans, Marie, Elinder, Carl-Gustaf, Wettermark, Bjorn, Wong, Tien Y., Cheng, Ching-Yu, Sokor, Riswana Banu Binte Mohamed Abdul, Wen, Chi-Pang, Tsao, Chwen-Keng, Tsai, Min-Kuang, Chen, Chien-Hua, Hosseinpanah, Farhad, Hadaegh, Farzad, Mirbolouk, Mohammadhassan, Solbu, Marit Dahl, Eriksen, Bjorn Odvar, Jenssen, Trond Geir, Eggen, Anne Elise, Lannfelt, Lars, Larsson, Anders, Ärnlöv, Johan, Bilo, Henk J. G., Landman, Gijs W. D., van Hateren, Kornelis J. J., Kleefstra, Nanne, Stempniewicz, Nikita, Cuddeback, John, Ciemins, Elizabeth, Levey, Andrew S., Chen, Jingsha, Kwak, Lucia, and Surapeneni, Aditya
- Abstract
IMPORTANCE: Early identification of individuals at elevated risk of developing chronic kidney disease (CKD) could improve clinical care through enhanced surveillance and better management of underlying health conditions. OBJECTIVE: To develop assessment tools to identify individuals at increased risk of CKD, defined by reduced estimated glomerular filtration rate (eGFR). DESIGN, SETTING, AND PARTICIPANTS: Individual-level data analysis of 34 multinational cohorts from the CKD Prognosis Consortium including 5 222 711 individuals from 28 countries. Data were collected from April 1970 through January 2017. A 2-stage analysis was performed, with each study first analyzed individually and summarized overall using a weighted average. Because clinical variables were often differentially available by diabetes status, models were developed separately for participants with diabetes and without diabetes. Discrimination and calibration were also tested in 9 external cohorts (n = 2 253 540). EXPOSURES: Demographic and clinical factors. MAIN OUTCOMES AND MEASURES: Incident eGFR of less than 60 mL/min/1.73 m(2). RESULTS: Among 4 441 084 participants without diabetes (mean age, 54 years, 38% women), 660 856 incident cases (14.9%) of reduced eGFR occurred during a mean follow-up of 4.2 years. Of 781 627 participants with diabetes (mean age, 62 years, 13% women), 313 646 incident cases (40%) occurred during a mean follow-up of 3.9 years. Equations for the 5-year risk of reduced eGFR included age, sex, race/ethnicity, eGFR, history of cardiovascular disease, ever smoker, hypertension, body mass index, and albuminuria concentration. For participants with diabetes, the models also included diabetes medications, hemoglobin A(1c), and the interaction between the 2. The risk equations had a median C statistic for the 5-year predicted probability of 0.845 (interquartile range [IQR], 0.789-0.890) in the cohorts without diabetes and 0.801 (IQR, 0.750-0.819) in the cohorts with diabetes. Calib
- Published
- 2019
- Full Text
- View/download PDF
66. Effectiveness of low-dose contrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and/or pancreas transplantation
- Author
-
Elinder, Carl-Gustaf, Andersson, Jan, Bolinder, Gunilla, and Tydén, Gunnar
- Published
- 1992
- Full Text
- View/download PDF
67. Association between Smoking and Chronic Renal Failure in a Nationwide Population-Based Case-Control Study
- Author
-
EJERBLAD, ELISABETH, FORED, C. MICHAEL, LINDBLAD, PER, FRYZEK, JON, DICKMAN, PAUL W., ELINDER, CARL-GUSTAF, MCLAUGHLIN, JOSEPH K., and NYRÉN, OLOF
- Published
- 2004
- Full Text
- View/download PDF
68. Absence of Association between Organic Solvent Exposure and Risk of Chronic Renal Failure: A Nationwide Population-Based Case-Control Study
- Author
-
Fored, C. Michael, Nise, Gun, Ejerblad, Elisabeth, Fryzek, Jon P., Lindblad, Per, McLaughlin, Joseph K., Elinder, Carl-Gustaf, and Nyrén, Olof
- Published
- 2004
- Full Text
- View/download PDF
69. The applicability of the measurement of urinary thioethers: A study of humans exposed to styrene during diet standardization
- Author
-
Aringer, Leif, Löf, Agneta, and Elinder, Carl-Gustaf
- Published
- 1991
- Full Text
- View/download PDF
70. Environmental Lead Exposure and Chronic Renal Disease
- Author
-
Elinder, Carl-Gustaf and Alvestrand, Anders
- Published
- 2003
71. Socio-economic status and chronic renal failure: a population-based case-control study in Sweden
- Author
-
Fored, Michael C., Ejerblad, Elisabeth, Fryzek, Jon P., Lambe, Mats, Lindblad, Per, Nyrén, Olof, and Elinder, Carl-Gustaf
- Published
- 2003
72. Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project
- Author
-
Runesson, Björn, primary, Trevisan, Marco, additional, Iseri, Ken, additional, Qureshi, Abdul Rashid, additional, Lindholm, Bengt, additional, Barany, Peter, additional, Elinder, Carl Gustaf, additional, and Carrero, Juan Jesus, additional
- Published
- 2019
- Full Text
- View/download PDF
73. FP391FRACTURE RISK IN NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (CKD): INCIDENCE, PREDICTORS AND SEQUELAE
- Author
-
Runesson, Björn, primary, Trevisan, Marco, additional, Iseri, Ken, additional, Bengt, Lindholm, additional, Peter, Barany, additional, Elinder, Carl-Gustaf, additional, and Carrero, Juan Jesus, additional
- Published
- 2019
- Full Text
- View/download PDF
74. Estimated Glomerular Filtration Rate and the Risk of Cancer
- Author
-
Xu, Hong, primary, Matsushita, Kunihiro, additional, Su, Guobin, additional, Trevisan, Marco, additional, Ärnlöv, Johan, additional, Barany, Peter, additional, Lindholm, Bengt, additional, Elinder, Carl-Gustaf, additional, Lambe, Mats, additional, and Carrero, Juan-Jesus, additional
- Published
- 2019
- Full Text
- View/download PDF
75. Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium
- Author
-
Inker, Lesley A., primary, Grams, Morgan E., additional, Levey, Andrew S., additional, Coresh, Josef, additional, Cirillo, Massimo, additional, Collins, John F., additional, Gansevoort, Ron T., additional, Gutierrez, Orlando M., additional, Hamano, Takayuki, additional, Heine, Gunnar H., additional, Ishikawa, Shizukiyo, additional, Jee, Sun Ha, additional, Kronenberg, Florian, additional, Landray, Martin J., additional, Miura, Katsuyuki, additional, Nadkarni, Girish N., additional, Peralta, Carmen A., additional, Rothenbacher, Dietrich, additional, Schaeffner, Elke, additional, Sedaghat, Sanaz, additional, Shlipak, Michael G., additional, Zhang, Luxia, additional, van Zuilen, Arjan D., additional, Hallan, Stein I., additional, Kovesdy, Csaba P., additional, Woodward, Mark, additional, Levin, Adeera, additional, Astor, Brad, additional, Appel, Larry, additional, Greene, Tom, additional, Chen, Teresa, additional, Chalmers, John, additional, Arima, Hisatomi, additional, Perkovic, Vlado, additional, Yatsuya, Hiroshi, additional, Tamakoshi, Koji, additional, Li, Yuanying, additional, Hirakawa, Yoshihisa, additional, Matsushita, Kunihiro, additional, Grams, Morgan, additional, Sang, Yingying, additional, Polkinghorne, Kevan, additional, Chadban, Steven, additional, Atkins, Robert, additional, Djurdjev, Ognjenka, additional, Liu, Lisheng, additional, Zhao, Minghui, additional, Wang, Fang, additional, Wang, Jinwei, additional, Ebert, Natalie, additional, Martus, Peter, additional, Tang, Mila, additional, Heine, Gunnar, additional, Emrich, Insa, additional, Seiler, Sarah, additional, Zawada, Adam, additional, Nally, Joseph, additional, Navaneethan, Sankar, additional, Schold, Jesse, additional, Shlipak, Michael, additional, Sarnak, Mark, additional, Katz, Ronit, additional, Hiramoto, Jade, additional, Iso, Hiroyasu, additional, Yamagishi, Kazumasa, additional, Umesawa, Mitsumasa, additional, Muraki, Isao, additional, Fukagawa, Masafumi, additional, Maruyama, Shoichi, additional, Hasegawa, Takeshi, additional, Fujii, Naohiko, additional, Wheeler, David, additional, Emberson, John, additional, Townend, John, additional, Landray, Martin, additional, Brenner, Hermann, additional, Schöttker, Ben, additional, Saum, Kai-Uwe, additional, Fox, Caroline, additional, Hwang, Shih-Jen, additional, Köttgen, Anna, additional, Schneider, Markus P., additional, Eckardt, Kai-Uwe, additional, Green, Jamie, additional, Kirchner, H Lester, additional, Chang, Alex R., additional, Ho, Kevin, additional, Ito, Sadayoshi, additional, Miyazaki, Mariko, additional, Nakayama, Masaaki, additional, Yamada, Gen, additional, Irie, Fujiko, additional, Sairenchi, Toshimi, additional, Yano, Yuichiro, additional, Kotani, Kazuhiko, additional, Nakamura, Takeshi, additional, Kimm, Heejin, additional, Mok, Yejin, additional, Chodick, Gabriel, additional, Shalev, Varda, additional, Wetzels, Jack F.M., additional, Blankestijn, Peter J., additional, van den Brand, Jan, additional, Inker, Lesley, additional, Peralta, Carmen, additional, Kollerits, Barbara, additional, Ritz, Eberhard, additional, Nitsch, Dorothea, additional, Roderick, Paul, additional, Fletcher, Astrid, additional, Bottinger, Erwin, additional, Ellis, Stephen B., additional, Nadukuru, Rajiv, additional, Ueshima, Hirotsugu, additional, Okayama, Akira, additional, Tanaka, Sachiko, additional, Okamura, Tomonori, additional, Kadota, Aya, additional, Kenealy, Timothy, additional, Elley, C Raina, additional, Drury, Paul L., additional, Ohkubo, Takayoshi, additional, Asayama, Kei, additional, Metoki, Hirohito, additional, Kikuya, Masahiro, additional, Nelson, Robert G., additional, Knowler, William C., additional, Bakker, Stephan JL., additional, Hak, Eelco, additional, Heerspink, Hiddo J.L., additional, Brunskill, Nigel, additional, Major, Rupert, additional, Shepherd, David, additional, Medcalf, James, additional, Jassal, Simerjot K., additional, Bergstrom, Jaclyn, additional, Ix, Joachim H., additional, Barrett-Connor, Elizabeth, additional, Kovesdy, Csaba, additional, Kalantar-Zadeh, Kamyar, additional, Sumida, Keiichi, additional, Muntner, Paul, additional, Warnock, David, additional, McClellan, William, additional, de Zeeuw, Dick, additional, Brenner, Barry, additional, Ikram, M Arfan, additional, Hoorn, Ewout J., additional, Dehghan, Abbas, additional, Carrero, Juan J., additional, Gasparini, Alessandro, additional, Wettermark, Björn, additional, Elinder, Carl-Gustaf, additional, Wong, Tien Yin, additional, Sabanayagam, Charumathi, additional, Cheng, Ching-Yu, additional, Visseren, Frank L.J., additional, Evans, Marie, additional, Segelmark, Mårten, additional, Stendahl, Maria, additional, Schön, Staffan, additional, Tangri, Navdeep, additional, Sud, Maneesh, additional, Naimark, David, additional, Wen, Chi-Pang, additional, Tsao, Chwen-Keng, additional, Tsai, Min-Kugng, additional, Chen, Chien-Hua, additional, Konta, Tsuneo, additional, Hirayama, Atsushi, additional, Ichikawa, Kazunobu, additional, Lannfelt, Lars, additional, Larsson, Anders, additional, Ärnlöv, Johan, additional, Bilo, Henk J.G., additional, Landman, Gijs W.D., additional, van Hateren, Kornelis J.J., additional, Kleefstra, Nanne, additional, Coresh (Chair, Josef, additional, Hallan, Stein, additional, Ballew, Shoshana H., additional, Chen, Jingsha, additional, Kwak, Lucia, additional, and Surapaneni, Aditya, additional
- Published
- 2019
- Full Text
- View/download PDF
76. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
- Author
-
Coresh, Josef, primary, Heerspink, Hiddo J L, additional, Sang, Yingying, additional, Matsushita, Kunihiro, additional, Arnlov, Johan, additional, Astor, Brad C, additional, Black, Corri, additional, Brunskill, Nigel J, additional, Carrero, Juan-Jesus, additional, Feldman, Harold I, additional, Fox, Caroline S, additional, Inker, Lesley A, additional, Ishani, Areef, additional, Ito, Sadayoshi, additional, Jassal, Simerjot, additional, Konta, Tsuneo, additional, Polkinghorne, Kevan, additional, Romundstad, Solfrid, additional, Solbu, Marit D, additional, Stempniewicz, Nikita, additional, Stengel, Benedicte, additional, Tonelli, Marcello, additional, Umesawa, Mitsumasa, additional, Waikar, Sushrut S, additional, Wen, Chi-Pang, additional, Wetzels, Jack F M, additional, Woodward, Mark, additional, Grams, Morgan E, additional, Kovesdy, Csaba P, additional, Levey, Andrew S, additional, Gansevoort, Ron T, additional, Appel, Lawrence J, additional, Greene, Tom, additional, Chen, Teresa K, additional, Chalmers, John, additional, Arima, Hisatomi, additional, Perkovic, Vlado, additional, Levin, Adeera, additional, Djurdjev, Ognjenka, additional, Tang, Mila, additional, Nally, Joseph, additional, Navaneethan, Sankar D, additional, Schold, Jesse D, additional, Weldegiorgis, Misghina, additional, Herrington, William G, additional, Smith, Margaret, additional, Hsu, C Yenchih, additional, Hwang, Shih-Jen, additional, Chang, Alex R, additional, Kirchner, H. Lester, additional, Green, Jamie A, additional, Ho, Kevin, additional, Marks, Angharad, additional, Prescott, Gordon, additional, Clark, Laura E, additional, Fluck, Nick, additional, Shalev, Varda, additional, Chodick, Gabriel, additional, Blankestijn, Peter J, additional, Van Zuilen, Arjan, additional, Van den Brand, Jan A, additional, Sarnak, Mark J, additional, Bottinger, Erwin, additional, Nadkarni, Girish N, additional, Ellis, Stephen G, additional, Nadukuru, Rajiv, additional, Metzger, Marie, additional, Flamant, Martin, additional, Houillier, Pascal, additional, Haymann, Jean-Philippe, additional, Froissart, Marc, additional, Kenealy, Timothy, additional, Elley, Raina C, additional, Collins, John F, additional, Drury, Paul L, additional, Cuddeback, John K, additional, Ciemins, Elizabeth L, additional, Stempniewicz, Rich, additional, Nelson, Robert G, additional, Knowler, William C, additional, Bakker, Stephen J, additional, Major, Rupert W, additional, Medcalf, James F, additional, Shepherd, David, additional, Barrett-Connor, Elizabeth, additional, Bergstrom, Jaclyn, additional, Ix, Joachim H, additional, Molnar, Miklos Z, additional, Sumida, Keiichi, additional, de Zeeuw, Dick, additional, Brenner, Barry, additional, Qureshi, Abdul R, additional, Elinder, Carl-Gustaf, additional, Runesson, Bjorn, additional, Evans, Marie, additional, Segelmark, Marten, additional, Stendahl, Maria, additional, Schön, Staffan, additional, Naimark, David M, additional, Tangri, Navdeep, additional, Sud, Maneesh, additional, Hirayama, Atsushi, additional, Ichikawa, Kazunobu, additional, Bilo, Henk JG, additional, Landman, Gijs WD, additional, Van Hateren, Kornelis JJ, additional, Kleefstra, Nanne, additional, Hallan, Stein I, additional, Ballew, Shoshana H, additional, Chen, Jingsha, additional, Kwak, Lucia, additional, Surapaneni, Aditya, additional, Parving, Hans-Henrik, additional, Rodby, Roger A., additional, Rohde, Richard D, additional, Lewis, Julia B, additional, Lewis, Edmund, additional, Perrone, Ronald D, additional, Abebe, Kaleab Z, additional, Hou, Fan F, additional, Xie, Di, additional, Hunsicker, Lawrence G, additional, Imai, Enyu, additional, Kobayashi, Fumiaki, additional, Makino, Hirofumi, additional, Remuzzi, Giuseppe, additional, Ruggenenti, Piero, additional, Eckardt, Kai-Uwe, additional, Gudmundsdottir, Hrefna, additional, Maciulaitis, Romaldas, additional, Manley, Tom, additional, Smith, Kimberly, additional, Stockbridge, Norman, additional, Thompson, Aliza, additional, Vetter, Thorsten, additional, Willis, Kerry, additional, and Zhang, Luxia, additional
- Published
- 2019
- Full Text
- View/download PDF
77. Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor
- Author
-
Donne, Rosemary L., Abbs, Ian, Barany, Peter, Elinder, Carl-Gustaf, Little, Mark, Conlon, Peter, and Goodship, Timothy H.J.
- Published
- 2002
- Full Text
- View/download PDF
78. Decreased glomerular filtration rate in solderers exposed to cadmium
- Author
-
Jarup, Lars, Persson, Bodil, and Elinder, Carl Gustaf
- Published
- 1995
79. Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy
- Author
-
Wijkström, Julia, González-Quiroz, Marvin, Hernandez, Mario, Trujillo, Zulma, Hultenby, Kjell, Ring, Anneli, Söderberg, Magnus, Aragón, Aurora, Elinder, Carl-Gustaf, and Wernerson, Annika
- Subjects
Nephrology ,urologic and male genital diseases - Abstract
BACKGROUND: Mesoamerican nephropathy (MeN) is a chronic kidney disease affecting rural inhabitants in Central America. We have previously described the renal morphology in 8 patients from El Salvador. To confirm the renal pathology, we have studied kidney biopsies from patients with MeN in Nicaragua. Follow-up urine and blood samples from both biopsy studies were collected to investigate the natural history. STUDY DESIGN: Case series. SETTINGS & PARTICIPANTS: In the kidney biopsy study, 19 male sugarcane workers in Nicaragua with suspected MeN were investigated with questionnaires, kidney biopsies, and blood and urine analysis. Inclusion criteria were age 20 to 65 years and plasma creatinine level of 1.13 to 2.49mg/dL or estimated glomerular filtration rate (eGFR) of 30 to 80mL/min/1.73m2. Exclusion criteria were proteinuria with protein excretion > 3g/24 h, uncontrolled hypertension, diabetes mellitus, or other known kidney disease. In the follow up-study, blood and urine from the kidney biopsy study in Nicaragua (n=18) and our previous biopsy study of MeN cases in El Salvador (n=7) were collected 1 to 1.5 and 2 to 2.5 years after biopsy, respectively. OUTCOMES: Renal morphology, clinical, and biochemical characteristics, change in eGFR per year. MEASUREMENTS: eGFR was calculated using the CKD-EPI creatinine (eGFRcr), cystatin C (eGFRcys), and creatinine-cystatin C (eGFRcr-cys) equations. RESULTS: In the kidney biopsy study, participants had a mean eGFRcr of 57 (range, 33-96) mL/min/1.73m2. 47% had low plasma sodium and 21% had low plasma potassium levels. 16 kidney biopsies were representative and showed glomerulosclerosis (mean, 38%), glomerular hypertrophy, and signs of chronic glomerular ischemia. Mild to moderate tubulointerstitial damage and mostly mild vascular changes were seen. In the follow up-study, median duration of follow-up was 13 (range, 13-27) months. Mean change in eGFRcr was -4.4±8.4 (range, -27.7 to 10.2) mL/min/1.73m2 per year. Most patients had stopped working with sugarcane cultivation. LIMITATIONS: 3 biopsy specimens had 4 or fewer glomeruli. CONCLUSIONS: This study confirms the renal morphology of MeN: chronic glomerular and tubulointerstitial damage with glomerulosclerosis and chronic glomerular ischemia. Follow-up data show that eGFRs, on average, deteriorated.
- Published
- 2017
80. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442–1451
- Author
-
Remy, Philippe, Audard, Vincent, Natella, Pierre André, Pelle, Gaëlle, Dussol, Bertrand, Leray-Moragues, Hélène, Bouachi, Khedidja, Dantal, Jacques, Vrigneaud, Laurence, Karras, Alexandre, Pourcine, Frank, Gatault, Philippe, Grimbert, Philippe, Ait Sahlia, Nawelle, Moktefi, Anissa, Daugas, Eric, Rigothier, Claire, Bastuji-Garin, Sylvie, Sahali, Dil, Aldigier, Jean Claude, Bataille, Pierre, Canaud, Bernard, Chauveau, Dominique, Combe, Christian, Choukroun, Gabriel, Cornec-Legall, Emilie, Dahan, Karine, Delahousse, Michel, Desvaux, Dominique, Deteix, Patrice, Durrbach, Antoine, Esnault, Vincent, Essig, Marie, Fievet, Patrick, Frouget, Thierry, Guerrot, Dominique, Godin, Michel, Gontiers-Picard, Annie, Gosselin, Morgane, Hanrotel-Saliou, Catherine, Heng, Anne-Elisabeth, Huart, Antoine, Humbert, Antoine, Kofman, Tomek, Hummel, Aurélie, Lang, Philippe, Laville, Maurice, Lemeur, Yannick, Malvezzi, Paolo, Matignon, Marie, Mesbah, Rafik, Moulin, Bruno, Muller, Sandrine, Olagne, Jerome, Pardon, Agathe, Provôt, François, Queffeulou, Guillaume, Plaisier, Emmanuelle, Raimbourg, Quentin, Rieu, Philippe, Stehlé, Thomas, Vanhille, Philippe, Astor, Brad, Levin, Adeera, Tang, Mila, Djurdjev, Ognjenka, Navaneethan, Sankar, Jolly, Stacey, Schold, Jesse, Nally, Joseph, Emberson, Jonathan, Townend, John, Landray, Martin, Feldman, Harold, Hsu, Chi-Yuan, Lash, James, Appel, Lawrence, Kalra, Philip, Ritchie, James, Maharajan, Raman, Middleton, Rachel, O’donoghue, Donal, Schneider, Markus, Kronenberg, Florian, Bärthlein, Barbara, Green, Jamie, Kirchner, H. Lester, Ho, Kevin, Marks, Angharad, Black, Corri, Prescott, Gordon, Fluck, Nick, Nakayama, Masaaki, Miyazaki, Mariko, Yamamoto, Tae, Yamada, Gen, Wang, Angela Yee-Moon, Cheung, Sharon, Wong, Sharon, Chu, Jessie, Wu, Henry, Garg, Amit, Mcarthur, Eric, Nash, Danielle, Shalev, Varda, Chodick, Gabriel, Blankestijn, Peter, Wetzels, Jack F.M., van Zuilen, Arjan, van den Brand, Jan, Inker, Lesley, Sarnak, Mark, Tighiouart, Hocine, Zhang, Haitao, Stengel, Bénédicte, Metzger, Marie, Flamant, Martin, Houillier, Pascal, Haymann, Jean-Philippe, Rios, Pablo, Mazzuchi, Nelson, Gadola, Liliana, Lamadrid, Verónica, Solá, Laura, Collins, John, Elley, C. Raina, Kenealy, Timothy, Moranne, Olivier, Couchoud, Cécile, Vigneau, Cécile, Brunskill, Nigel, Major, Rupert, Shepherd, David, Medcalf, James, Kovesdy, Csaba, Kalantar-Zadeh, Kamyar, Sumida, Keiichi, Potukuchi, Praveen, Heerspink, Hiddo J.L., de Zeeuw, Dick, Brenner, Barry, Carrero, Juan Jesus, Gasparini, Alessandro, Qureshi, Abdul Rashid, Elinder, Carl-Gustaf, Visseren, Frank L.J., van Der Graaf, Yolanda, Evans, Marie, Stendahl, Maria, Schön, Staffan, Segelmark, Mårten, Prütz, Karl-Göran, Naimark, David, Tangri, Navdeep, Mark, Patrick, Traynor, Jamie, Geddes, Colin, Thomson, Peter, Chang, Alex, Gansevoort, Ron, Köttgen, Anna, Levey, Andrew, Zhang, Luxia, Ballew, Shoshana, Chen, Jingsha, Coresh, Josef, Grams, Morgan, Kwak, Lucia, Matsushita, Kunihiro, Sang, Yingying, Surapaneni, Aditya, Woodward, Mark, Eckardt, Kai-Uwe, Hemmelgarn, Brenda, Wheeler, David, Winkelmayer, Wolfgang, Davis, John, Green, Danielle, Cheung, Michael, Green, Tanya, Mcmahan, Melissa, Molnar, Miklos, Service de néphrologie [CHU Henri Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Henri Mondor, Assistance Publique-Hôpitaux de Paris, Department of Pathology, Centre hospitalier universitaire Henri Mondor, F-94000 Créteil, France, Department of Nephrology and Transplantation, Foch Hospital, Chirurgie urologique et transplantation rénale [Hôpital de la Conception - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Service de néphrologie et transplantation, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut Transplantation Urologie et Néphrologie, Centre hospitalier universitaire de Nantes (CHU Nantes), Service de Néphrologie [Valenciennes], Centre Hospitalier de Valenciennes, Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Service de Néphrologie CHU TOURS, INSERM U955, équipe 21, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), UMR 1599, Centre National de la Recherche Scientifique (CNRS), Department of Nephrology, Transplantation and Dialysis, Bordeaux, Laboratoire d'Investigation Clinique (LIC), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Henri Mondor, Université de Lausanne = University of Lausanne (UNIL), Service de Néphrologie et Immunopathologie Clinique, Centre Hospitalier Universitaire de Toulouse, PRES Université de Toulouse, CHU Bordeaux [Bordeaux], Unité Médicale de Soins Intensifs, CHU Amiens-Picardie, CHRU Brest - Service de Nephrologie (CHU - BREST - Nephrologie), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Service de Département de Néphrologie = Service de Néphrologie et Dialyses [CHU Tenon], CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de transplantation rénale, Hôpital Foch [Suresnes], Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Service Néphrologie, Pôle REUNNIRH, CHU Clermont-Ferrand, U542, Institut National de la Santé et de la Recherche Médicale (INSERM), Service de néphrologie, Centre Hospitalier Universitaire de Nice (CHU Nice), Service de Néphrologie, Dialyse, Transplantations [CHU Limoges], CHU Limoges, Univers, Transport, Interfaces, Nanostructures, Atmosphère et environnement, Molécules (UMR 6213) (UTINAM), Institut national des sciences de l'Univers (INSU - CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), CHU Pontchaillou [Rennes], Service de Néphrologie [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Nouvelles Cibles Pharmacologiques de la Protection Endothéliale et de l'Insuffisance Cardiaque (EnVI), Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Néphrologie, Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)-Hôpital de la Cavale Blanche - CHRU Brest (CHU - BREST ), Unité de Nutrition Humaine (UNH), Institut National de la Recherche Agronomique (INRA)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Service de néphrologie, dialyse, aphérèses et transplantation, CHU Grenoble-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), CH Boulogne sur Mer, Service de Néphrologie et Transplantation, CHU Strasbourg, CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de Néphrologie [CHPC - Site Louis Pasteur], Site Louis Pasteur [CHPC], CH Centre Hospitalier Public du Cotentin (CHPC)-CH Centre Hospitalier Public du Cotentin (CHPC), Remodelage et Reparation du Tissu Renal, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Néphrologie [Bichat - Claude Bernard], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Centre Hospitalier Universitaire de Reims (CHU Reims), Université Paris Descartes - Faculté de Médecine (UPD5 Médecine), Université Paris Descartes - Paris 5 (UPD5), Service de médecine interne et néphrologie, CH Valenciennes, Division of Nephrology [Vancouver, BC, Canada], University of British Columbia (UBC), Aberdeen University, Fraunhofer Institute for Secure Information Technology [Darmstadt] (Fraunhofer SIT), Fraunhofer (Fraunhofer-Gesellschaft), Division of genetic epidemiology, HMNC Brain Health-Molecular and Clinical Pharmacology-Innsbruck Medical University [Austria] (IMU), Department of electronic engineering, Chang Gung University, Institute of Applied Health Sciences, University of Aberdeen, Department of Medicine, The University of Hong Kong (HKU), Department of Nephrology [Utrecht, Pays-Bas], University Medical Center [Utrecht], Department of Nephrology [Nijmegen, The Netherlands], Radboud University Medical Center [Nijmegen], Department of nephrology [Nimègue, Pays-Bas], Radboud Institute for Health Sciences [Nimègue, Pays-Bas], Radboud University Medical Center [Nijmegen]-Radboud University Medical Center [Nijmegen], Tufts Medical Center, Nanjing University of Aeronautics and Astronautics [Nanjing] (NUAA), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Physiologie [Bichat-Claude Bernard], Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Service de Physiologie [Georges-Pompidou], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5), Des Maladies Rénales Rares aux Maladies Fréquentes, Remodelage et Réparation, Center for Research in Agricultural Genomics, Directora Division Epidemiologia [Montevideo, Uruguay], Ministerio de Salud Publica, Hôpital Pasteur [Nice] (CHU)-Centre Hospitalier Universitaire de Nice (CHU Nice), Agence de la biomédecine [Saint-Denis la Plaine], Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Division of Nephrology, Department of Medicine, Vanderbilt University School of Medicine [Nashville], Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet [Stockholm], Julius Center for Health Sciences and Primary Care, Division of Drug Research/Clinical Pharmacology, Department of Medicine and Health, Faculty of Health Sciences, Linköping University (LIU), Department of Nephrology [Groningue, Pays-Bas], University Medical Center Groningen [Groningen] (UMCG), Renal Division [Beijing, China], Peking University [Beijing], The Georges Institute for International Health, The University of Sydney, Department of Nephrology and Hypertension [Erlangen, Germany], Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Baylor College of Medicine (BCM), Baylor University, Université de Lausanne (UNIL), Service de Néphrologie et Dialyses [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble, Service de néphrologie [CHPC, Cherbourg-en-Cotentin], CHPC - Site Louis Pasteur, Centre Hospitalier Public du Cotentin (CHPC)-Centre Hospitalier Public du Cotentin (CHPC), Innsbruck Medical University [Austria] (IMU)-HMNC Brain Health-Molecular and Clinical Pharmacology, Radboud University Medical Centre [Nijmegen, The Netherlands], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )-Institut National de la Santé et de la Recherche Médicale (INSERM)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Université d'Angers (UA), Peking University First Hospital [China]-Peking University Institute of Nephrology [China], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Henri Mondor [Créteil], Service Médecine interne et immunopathologie clinique [CHU Toulouse], Pôle IUCT [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), HMNC Brain Health-Molecular and Clinical Pharmacology-Innsbruck Medical University = Medizinische Universität Innsbruck (IMU), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Henri Mondor, Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital de la Conception [CHU - APHM] (LA CONCEPTION ), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut Mondor de Recherche Biomédicale (IMRB), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Tenon [APHP], Centre Hospitalier Universitaire de Clermont-Ferrand, Université de Rouen Normandie (UNIROUEN), Unité de Nutrition Humaine - Clermont Auvergne (UNH), Institut National de la Recherche Agronomique (INRA)-Université Clermont Auvergne (UCA), Service de Néphrologie, Dialyse, Aphérèses et Transplantation [CHU Grenoble], Centre Hospitalier Universitaire [Grenoble] (CHU), CHU Saint-Antoine [APHP], Centre Hospitalier du Cotentin, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Université Paris Diderot - Paris 7 (UPD7), Fraunhofer Institute for Secure Information Technology [Darmstadt] (SIT), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC), Méthodes Algorithmes pour l'Ordonnancement et les Réseaux (MAORE), Laboratoire d'Informatique de Robotique et de Microélectronique de Montpellier (LIRMM), and Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Nephrology ,medicine.medical_specialty ,[SDV]Life Sciences [q-bio] ,media_common.quotation_subject ,030232 urology & nephrology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,In patient ,030212 general & internal medicine ,mycophenolate ,media_common ,clinical trial ,Art ,medicine.disease ,Optimal management ,Treatment efficacy ,3. Good health ,Transplantation ,Cohort ,idiopathic nephrotic syndrome ,Humanities ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,steroids ,Kidney disease ,Cohort study - Abstract
The Chronic Kidney Disease (CKD) Prognosis Consortium is a collaborative author of the above-mentioned article. The CKD Prognosis Consortium investigators/collaborators are as follows: • African American Study of Kidney Disease and Hypertension (AASK): Brad Astor, Lawrence J. Appel; Canadian Study of Prediction of Death, Dialysis and Interim Cardiovascular Events (CanPREDDICT): Adeera Levin, Mila Tang, Ognjenka Djurdjev; Cleveland Clinic CKD Registry Study (CCF): Sankar D. Navaneethan, Stacey E. Jolly, Jesse D. Schold, Joseph V. Nally Jr.; Chronic Renal Impairment in Birmingham (CRIB): David C. Wheeler, Jonathan Emberson, John Townend, Martin Landray; Chronic Renal Insufficiency Cohort Study (CRIC): Harold I. Feldman, Chi-yuan Hsu, James P. Lash, Lawrence J. Appel; Chronic Renal Insufficiency Standards Implementation Study (CRISIS): Philip A. Kalra, James P. Ritchie, Raman Maharajan, Rachel J. Middleton, Donal J. O'Donoghue; German Chronic Kidney Disease Study (GCKD): Kai-Uwe Eckardt, Markus P. Schneider, Anna Kottgen, Florian Kronenberg, Barbara Barthlein; Geisinger Health System: Alex R. Chang, Jamie A. Green, H. Lester Kirchner, Kevin Ho; Grampian Laboratory Outcomes, Morbidity and Mortality Studies – 2 (GLOMMS2): Angharad Marks, Corri Black, Gordon J. Prescott, Nick Fluck; Gonryo Study: Masaaki Nakayama, Mariko Miyazaki, Tae Yamamoto, Gen Yamada; Hong Kong CKD Studies: Angela Yee-Moon Wang, Sharon Cheung, Sharon Wong, Jessie Chu, Henry Wu; Ontario Institute for Clinical Evaluative Sciences, Provincial Kidney, Dialysis and Transplantation program (ICES KDT): Amit X. Garg, Eric McArthur, Danielle M. Nash; Maccabi Health System: Varda Shalev, Gabriel Chodick; Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of a Nurse Practitioner (MASTERPLAN): Peter J. Blankestijn, Jack F.M. Wetzels, Arjan D. van Zuilen, Jan A. van den Brand; Modification of Diet in Renal Disease Study (MDRD): Andrew S. Levey, Lesley A. Inker, Mark J. Sarnak, Hocine Tighiouart; Nanjing CKD Network Cohort Study (Nanjing CKD): Haitao Zhang; NephroTest Study (NephroTest): Benedicte Stengel, Marie Metzger, Martin Flamant, Pascal Houillier, Jean-Philippe Haymann; National Renal Healthcare Program – Uruguay (NRHP-URU): Pablo G. Rios, Nelson Mazzuchi, Liliana Gadola, Veronica Lamadrid, Laura Sola; New Zealand Diabetes Cohort Study (NZDCS): John F. Collins, C. Raina Elley, Timothy Kenealy; Parcours de Soins des Personnes Agees (PSPA): Olivier Moranne, Cecile Couchoud, Cecile Vigneau; Primary-Secondary Care Partnership to Prevent Adverse Outcomes in Chronic Kidney Disease (PSP CKD): Nigel J. Brunskill, Rupert W. Major, David Shepherd, James F. Medcalf; Racial and Cardiovascular Risk Anomalies in CKD Cohort (RCAV): Csaba P. Kovesdy, Kamyar Kalantar-Zadeh, Miklos Z. Molnar, Keiichi Sumida, Praveen K. Potukuchi; Reduction of Endpoints in Non-insulin Dependent Diabetes Mellitus with the Angiotensin II Antagonist Losartan (RENAAL): Hiddo J.L. Heerspink, Dick de Zeeuw, Barry Brenner; Stockholm CREAtinine Measurements Cohort (SCREAM): Juan Jesus Carrero, Alessandro Gasparini, Abdul Rashid Qureshi, Carl-Gustaf Elinder; Second Manifestations of ARTerial Disease Study (SMART): Frank L.J. Visseren, Yolanda van der Graaf; Swedish Renal Registry CKD Cohort (SRR CKD): Marie Evans, Maria Stendahl, Staffan Schon, Marten Segelmark, Karl-Goran Prutz; Sunnybrook Cohort: David M. Naimark, Navdeep Tangri; West of Scotland CKD Study: Patrick B. Mark, Jamie P. Traynor, Colin C. Geddes, Peter C. Thomson.• CKD Prognosis Consortium Steering Committee: Alex R. Chang, Josef Coresh (Chair), Ron T. Gansevoort, Morgan E. Grams, Anna Kottgen, Andrew S. Levey, Kunihiro Matsushita, Mark Woodward, Luxia Zhang.• CKD Prognosis Consortium Data Coordinating Center: Shoshana H. Ballew (Assistant Project Director), Jingsha Chen (Programmer), Josef Coresh (Principal Investigator), Morgan E. Grams (Director of Nephrology Initiatives), Lucia Kwak (Programmer), Kunihiro Matsushita (Director), Yingying Sang (Lead Programmer), Aditya Surapaneni (Programmer), Mark Woodward (Senior Statistician).• Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference on Prognosis and Optimal Management of Patients with Advanced CKD: Kai-Uwe Eckardt (Conference Co-Chair), Brenda R. Hemmelgarn (Conference Co-Chair), David C. Wheeler (KDIGO Co-Chair), Wolfgang C. Winkelmayer (KDIGO Co-Chair), John Davis (CEO), Danielle Green (Managing Director), Michael Cheung (Chief Scientific Officer), Tanya Green (Communications Director), Melissa McMahan (Programs Director).
- Published
- 2018
81. Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project.
- Author
-
Runesson, Björn, Trevisan, Marco, Iseri, Ken, Qureshi, Abdul Rashid, Lindholm, Bengt, Barany, Peter, Elinder, Carl Gustaf, and Carrero, Juan Jesus
- Subjects
CHRONIC kidney failure ,HIP fractures ,DISEASE complications ,CARDIOVASCULAR diseases ,GLOMERULAR filtration rate ,FRACTURE healing - Abstract
Introduction People undergoing maintenance dialysis are at high risk for fractures, but less is known about fracture incidence and associated outcomes in earlier stages of chronic kidney disease (CKD). Methods We conducted an observational analysis from the Stockholm Creatinine Measurement project, a Swedish health care utilization cohort during 2006–11. We identified all adults with confirmed CKD Stages 3–5 and no documented history of fractures and extracted information on comorbid history, ongoing medication, cardiovascular events and death. We studied incidence rates of fractures (overall and by location), with the estimated glomerular filtration rate (eGFR) as time-dependent exposure. We then studied hazard ratios [HRs and 95% confidence intervals (CIs)] for the events of death and major adverse cardiac events (MACE) using Cox regression with fracture as time-varying exposure. Results We identified 68 764 individuals with confirmed CKD (mean age 79 years, 56% women). During a median follow-up of 2.7 years, 9219 fractures occurred, of which 3105 were hip fractures. A more severe CKD stage was associated with a higher risk of fractures, particularly hip fractures: compared with CKD Stage 3a, the adjusted HR was 1.10 (95% CI 1.02–1.19), 1.32 (1.17–1.49) and 2.47 (1.94–3.15) for CKD Stage 3b, 4 and 5, respectively. Spline curves suggested a linear association with fracture risk with an eGFR <30 mL/min/1.73 m
2 . Compared with non-fracture periods, incident fracture was associated with a 4-fold increased mortality within 90 days [HR 4.21 (95% CI 3.95–4.49)]. The risk remained elevated beyond 90 days [HR 1.47 (95% CI 1.40–1.54)] and was stronger after hip fractures. Post-fracture MACE risk was also highest in the first 90 days [HR 4.02 (95% CI 3.73–4.33)], particularly after hip fractures, and persisted beyond 90 days [HR 1.20 (95% CI 1.10–1.30)]. Conclusion Our findings highlight the commonness of fractures and the increased risk for subsequent adverse outcomes in CKD patients. These results may inform clinical decisions regarding post-fracture clinical surveillance and fracture prevention strategies. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
82. FP341PLASMA POTASSIUM AND THE RISK OF MORTALITY: A TIME-DEPENDENT ANALYSIS FROM THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
- Author
-
Trevisan, Marco, primary, Evans, Marie, additional, Xu, Hairong, additional, Lindholm, Bengt, additional, Barany, Peter, additional, Elinder, Carl-Gustaf, additional, and Carrero, Juan Jesus, additional
- Published
- 2018
- Full Text
- View/download PDF
83. SP330AEGFR AND THE RISK OF CANCER: THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
- Author
-
Xu, Hong, primary, Su, Guobin, additional, Trevisan, Marco, additional, Elinder, Carl-Gustaf, additional, Barany, Peter, additional, Lindholm, Bengt, additional, and Carrero, Juan Jesus, additional
- Published
- 2018
- Full Text
- View/download PDF
84. SaO023OPTIMAL PLASMA POTASSIUM RANGES FOR MORTALITY PREDICTION ACROSS CHRONIC KIDNEY DISEASE STAGES; THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
- Author
-
Gasparini, Alessandro, primary, Evans, Marie, additional, Xu, Hairong, additional, Elinder, Carl-Gustaf, additional, and Carrero, Juan-Jesus, additional
- Published
- 2018
- Full Text
- View/download PDF
85. Lower serum calcium is independently associated with CKD progression
- Author
-
Janmaat, Cynthia J., primary, van Diepen, Merel, additional, Gasparini, Alessandro, additional, Evans, Marie, additional, Qureshi, Abdul Rashid, additional, Ärnlöv, Johan, additional, Barany, Peter, additional, Elinder, Carl-Gustaf, additional, Rotmans, Joris I., additional, Vervloet, Marc, additional, Dekker, Friedo W., additional, and Carrero, Juan Jesus, additional
- Published
- 2018
- Full Text
- View/download PDF
86. Morphological and clinical findings in Sri Lankan patients with chronic kidney disease of unknown cause (CKDu): Similarities and differences with Mesoamerican Nephropathy
- Author
-
Wijkström, Julia, primary, Jayasumana, Channa, additional, Dassanayake, Rajeewa, additional, Priyawardane, Nalin, additional, Godakanda, Nimali, additional, Siribaddana, Sisira, additional, Ring, Anneli, additional, Hultenby, Kjell, additional, Söderberg, Magnus, additional, Elinder, Carl-Gustaf, additional, and Wernerson, Annika, additional
- Published
- 2018
- Full Text
- View/download PDF
87. Evidence of Aluminium Accumulation in Aluminium Welders
- Author
-
Elinder, Carl-Gustaf, Ahrengart, Leif, Lidums, Vitauts, Pettersson, Erna, and Sjögren, Bengt
- Published
- 1991
88. Incidence of Renal Stones among Cadmium Exposed Battery Workers
- Author
-
Järup, Lars and Elinder, Carl Gustaf
- Published
- 1993
89. Biological monitoring of toxic metals
- Author
-
Friberg, Lars and Elinder, Carl-Gustaf
- Published
- 1993
90. Assessment of genotoxic exposure in Swedish coke-oven work by different methods of biological monitoring
- Author
-
Reuterwall, Christina, Aringer, Leif, Elinder, Carl-Gustaf, Rannug, Agneta, Levin, Jan-Olof, Juringe, Leif, and Önfelt, Agneta
- Published
- 1991
91. Pesticide poisonings in Costa Rica
- Author
-
Wesseling, Catharina, Castillo, Luisa, and Elinder, Carl-Gustaf
- Published
- 1993
92. Fatal cadmium-induced pneumonitis
- Author
-
Seidal, Kristin, Jörgensen, Nils, Elinder, Carl-Gustaf, Sjögren, Bengt, and Vahter, Marie
- Published
- 1993
93. Minor effects of low exposure to inorganic mercury on the human immune system
- Author
-
Langworth, Sven, Elinder, Carl-Gustaf, and Sundqvist, Karl-Gösta
- Published
- 1993
94. Biological half-time of cadmium in the blood of workers after cessation of exposure
- Author
-
Järup, Lars, Rogenfelt, Artur, Elinder, Carl-Gustaf, Nogawa, Koji, and Kjellström, Tord
- Published
- 1983
95. Chromosome changes in workers (smokers and nonsmokers) exposed to automobile fuels and exhaust gases
- Author
-
Fredga, Karl, Dävring, Lars, Sunner, Margareta, Bengtsson, Bengt O, Elinder, Carl-Gustaf, Sigtryggsson, Per, and Berlin, Maths
- Published
- 1982
96. Decreased blood lead levels in residents of Stockholm for the period 1980— 1984
- Author
-
Elinder, Carl-Gustaf, Friberg, Lars, Lind, Birger, Nilsson, Bo, Svartengren, Magnus, and Övermark, Ingela
- Published
- 1986
97. eGFR and the Risk of Community-Acquired Infections
- Author
-
Xu, Hong, Gasparini, Alessandro, Ishigami, Junichi, Mzayen, Khaled, Su, Guobin, Barany, Peter, Ärnlöv, Johan, Lindholm, Bengt, Elinder, Carl Gustaf, Matsushita, Kunihiro, Carrero, Juan Jesus, Xu, Hong, Gasparini, Alessandro, Ishigami, Junichi, Mzayen, Khaled, Su, Guobin, Barany, Peter, Ärnlöv, Johan, Lindholm, Bengt, Elinder, Carl Gustaf, Matsushita, Kunihiro, and Carrero, Juan Jesus
- Abstract
Background and objectives Community-acquired infections are common, contributing to adverse outcomes and increased health care costs. We hypothesized that, with lower eGFR, the incidence of community-acquired infections increases, whereas the pattern of site-specific infections varies. Design, setting, participants, & measurements Among 1,139,470 health care users (meanage=52 +/- 18 years old, 53% women) from the Stockholm CREAtinine Measurements Project, we quantified the associations of eGFR with the risk of infections, overall and major types, over 12 months. Results A total of 106,807 counts of infections were recorded throughout 1,128,313 person-years. The incidence rate of all infections increased with lower eGFR from 74/1000 person-years for individuals with eGFR=90-104 ml/min per 1.73m(2) to 419/1000 person-years for individuals with eGFR<30 ml/min per 1.73m(2). Compared with eGFR of 90-104 ml/min per 1.73 m(2), the adjusted incidence rate ratios of community-acquired infections were 1.08 (95% confidence interval, 1.01 to 1.14) for eGFR of 30-59 ml/min per 1.73m(2) and 1.53 (95% confidence interval, 1.39 to 1.69) for eGFR<30 ml/min per 1.73 m(2). The relative proportions of lower respiratory tract infection, urinary tract infection, and sepsis became increasingly higher along with lower eGFR strata (e.g., low respiratory tract infection accounting for 25% versus 15% of community-acquired infections in eGFR<30 versus 90-104 ml/min per 1.73m(2), respectively). Differences in incidence associated with eGFR were in general consistent for most infection types, except for nervous system and upper respiratory tract infections, for which no association was observed. Conclusions This region-representative health care study finds an excess community-acquired infections incidence in individuals with mild to severe CKD. Lower respiratory tract infection, urinary tract infection, and sepsis are major infections in CKD.
- Published
- 2017
- Full Text
- View/download PDF
98. Re : Byber et al. in Critical Reviews in Toxicology 2016;46:191-240
- Author
-
Elinder, Carl-Gustaf, Nordberg, Gunnar F, Elinder, Carl-Gustaf, and Nordberg, Gunnar F
- Published
- 2017
- Full Text
- View/download PDF
99. Biological Monitoring of Toxic Metals - Overview
- Author
-
Elinder, Carl-Gustaf, Gerhardsson, Lars, Oberdoerster, Guenter, Clarkson, Thomas W., editor, Miller, Morton W., editor, Friberg, Lars, editor, Nordberg, Gunnar F., editor, and Sager, Polly R., editor
- Published
- 1988
- Full Text
- View/download PDF
100. Chapter 17 - Renal Effects of Exposure to Metals
- Author
-
Barregard, Lars and Elinder, Carl-Gustaf
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.